Research output per year
Research output per year
Personal profile
specialisation
Hospital Pharmacy
Research interests
Pharmacology of CFTR modulators in Cystic Fibrosis
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
- 6 Article
-
Correlation between trough concentration and AUC for elexacaftor, tezacaftor and ivacaftor
Vonk, S. E. M., Altenburg, J., Mathôt, R. A. A. & Amsterdam Mucociliary Clearance Disease (AMCD) research group, 2024, (E-pub ahead of print) In: Journal of cystic fibrosis.Research output: Contribution to journal › Article › Academic › peer-review
Open Access1 Citation (Scopus) -
Stepwise Introduction of Elexacaftor-Tezacaftor-Ivacaftor in Patients With Cystic Fibrosis and Liver Cirrhosis Child-Pugh A or B Using Clinical and Therapeutic Drug Monitoring: A Case Series
Vonk, S. E. M., Lub, R., Weersink, E. J. M. & Amsterdam mucociliary clearance disease research group, 2023, (E-pub ahead of print) In: Clinical therapeutics.Research output: Contribution to journal › Article › Academic › peer-review
Open Access1 Citation (Scopus) -
No drug-drug interaction between tezacaftor-ivacaftor and clofazimine: A case report.
Amsterdam Mucociliary Clearance Disease (AMCD) research group, 21 Jan 2022, In: Journal of cystic fibrosis. 21, 1, p. e5-e7Research output: Contribution to journal › Article › Academic › peer-review
Open Access2 Citations (Scopus) -
Real-life efficacy and safety of elexacaftor/tezacaftor/ivacaftor on severe cystic fibrosis lung disease patients
Amsterdam Mucociliary Clearance Disease (AMCD) research group, 1 Dec 2022, In: Pharmacology research & perspectives. 10, 6, p. e01015 e01015.Research output: Contribution to journal › Article › Academic › peer-review
Open Access9 Citations (Scopus) -
Tobramycin and vestibulotoxicity: Retrospective analysis of four cases
Vonk, S. E. M., Weersink, E. J. M., Majoor, C. J. & Kemper, M. M., 22 Mar 2022, In: European Journal of Hospital Pharmacy. ejhpharm-2020-002588.Research output: Contribution to journal › Article › Academic › peer-review
Open Access2 Citations (Scopus)